Guggenheim Maintains Buy on DraftKings, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Negative 75.0%

Neg 75% Neu 0% Pos 0%

Guggenheim analyst Vamil Divan maintains DraftKings (NASDAQ:DKNG) with a Buy and lowers the price target from $37 to $35.